Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 85509-1014

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 85509-1014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (1014 Cyclobenzaprine 10mg)

Label (1014 Cyclobenzaprine 10mg)
Label for Cyclobenzaprine Hydrochloride Tablets USP 10 mg, containing 30 film-coated tablets. The label includes the NDC 85509-1014-3 and states the product is Rx only. Manufactured by Rubicon Research Private Limited and repackaged by PHOENIX RX LLC, Hatboro, PA. Additional details cover storage instructions, child safety warnings, and a QR code for prescribing information.*
FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Image (Cyclobenzaprine HCl Tabs Structure)
Chemical structure of cyclobenzaprine hydrochloride displaying its molecular framework and hydrochloride group as part of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.